Showing results (661-670 of 25,717) with videos related to

Sort By:
Pageof 2,572
Circulation|June 10, 2009
Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimonyMarco Ranucci, Serenella Castelvecchio, Lorenzo Menicanti, et al.
Circulation|June 10, 2009
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative studySteven Goldman, Madeline McCarren, Eugene Morkin, et al.
Circulation|June 10, 2009
Predicting the 30-year risk of cardiovascular disease: the framingham heart studyMichael J Pencina, Ralph B D'Agostino, Martin G Larson, et al.
Circulation|June 10, 2009
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood instituteDouglas S Lee, Philimon Gona, Ramachandran S Vasan, et al.
Circulation|February 25, 2009
Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarctionSusan Cheng, David A Morrow, Sarah Sloan, et al.
Circulation|February 25, 2009
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical supportScot J Matkovich, Derek J Van Booven, Keith A Youker, et al.
Circulation|June 24, 2009
Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgeryRavi Gill, Mike Herbertson, Alain Vuylsteke, et al.
Circulation|December 1, 1991
Use of radiofrequency current to ablate accessory connections in childrenM Dick, B K O'Connor, G A Serwer, et al.
Circulation|December 1, 1991
Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-AP J Rogers, G M Tyce, R M Weinshilboum, et al.
Circulation|December 1, 1991
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectorisU Thadani, S R Zellner, S Glasser, et al.
Pageof 2,572